SCHEMBL16309175

SCHEMBL16309175

COCCS(=O)(=O)c1ccc(-c2cc3cnc(Nc4ccc(N5C[C@@H](C)N[C@@H](C)C5)c(F)c4)nc3n(-c3ccccc3)c2=O)c(C)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 2/20 0.44
FGFR4 P22455 2/20 0.44
KDR P35968 1/20 0.44
PAK3 O75914 1/20 0.40
PAK4 O96013 1/20 0.40
LIMK1 P53667 1/20 0.40
LIMK2 P53671 1/20 0.40
PAK1 Q13153 1/20 0.40
PAK2 Q13177 1/20 0.40
PKN1 Q16512 1/20 0.40
FGFR2 P21802 1/20 0.39
FGFR3 P22607 1/20 0.39
TNK2 Q07912 7/20 0.39
JAK2 O60674 5/20 0.38
JAK1 P23458 2/20 0.38
CDK4 P11802 2/20 0.37
CCND1 P24385 2/20 0.37
CCND2 P30279 1/20 0.37
CCND3 P30281 1/20 0.37
WEE1 P30291 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16310840 0.92 FGFR1 (0.43) FGFR1FGFR4KDRPAK3PAK4
SCHEMBL15036001 0.92 FGFR1 (0.43) FGFR1FGFR4KDRPAK3PAK4
SCHEMBL15281052 0.92 FGFR1 (0.43) FGFR1FGFR4KDRPAK3PAK4
SCHEMBL14681974 0.80 FGFR1 (0.45) FGFR1FGFR4KDRPAK3PAK4
SCHEMBL16309188 0.77 TNK2 (0.48) PAK3PAK4LIMK1LIMK2PAK1
SCHEMBL15036103 0.76 PAK3 (0.54) PAK3PAK4LIMK1LIMK2PAK1
SCHEMBL15041867 0.73 FGFR1 (0.47) FGFR1FGFR4KDRPAK3PAK4
SCHEMBL15035693 0.72 TNK2 (0.47) FGFR1FGFR4KDRPAK3PAK4
SCHEMBL15036096 0.71 FGFR1 (0.45) FGFR1FGFR4KDRPAK3PAK4
SCHEMBL15036081 0.71 WEE1 (0.45) FGFR1FGFR4KDRPAK3PAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8912203-B2 6-(sulfonylaryl)pyrido[2,3-D]pyrimidin-7(8H)-ones for the treatment of CNS disorders AFRAXIS HOLDINGS, INC. (US) 2014-12-16 US disclosed